Prostaglandin	B:C3813211
E2	I:C3813211
produced	O
following	O
infection	O
with	O
Theiler	O
's	I:C0206425
virus	I:C0206425
promotes	O
the	O
pathogenesis	O
of	O
demyelinating	O
disease	I:C0011303
.	O

Prostaglandin	O
E2	I:C3813211
produced	O
following	O
infection	B:C3714514
with	O
Theiler	O
's	I:C0206425
virus	I:C0206425
promotes	O
the	O
pathogenesis	O
of	O
demyelinating	O
disease	I:C0011303
.	O

Prostaglandin	O
E2	I:C3813211
produced	O
following	O
infection	O
with	O
Theiler	B:C0206425
's	I:C0206425
virus	I:C0206425
promotes	O
the	O
pathogenesis	O
of	O
demyelinating	O
disease	I:C0011303
.	O

Prostaglandin	O
E2	I:C3813211
produced	O
following	O
infection	O
with	O
Theiler	O
's	I:C0206425
virus	I:C0206425
promotes	O
the	O
pathogenesis	B:C0699748
of	O
demyelinating	O
disease	I:C0011303
.	O

Prostaglandin	O
E2	I:C3813211
produced	O
following	O
infection	O
with	O
Theiler	O
's	I:C0206425
virus	I:C0206425
promotes	O
the	O
pathogenesis	O
of	O
demyelinating	B:C0011303
disease	I:C0011303
.	O

Infection	B:C3714514
of	O
various	O
cells	O
with	O
Theiler	O
's	I:C0206425
murine	I:C0206425
encephalomyelitis	I:C0206425
virus	I:C0206425
(	O
Theiler	O
's	I:C0206425
murine	I:C0206425
encephalomyelitis	I:C0206425
virus	I:C0206425
)	O
activates	O
the	O
TLR	O
-	O
and	O
melanoma	O
differentiation	I:C3271892
-	I:C3271892
associated	I:C3271892
gene	I:C3271892
5	I:C3271892
(	I:C3271892
MDA5	I:C3271892
)	I:C3271892
-	I:C3271892
dependent	I:C3271892
pathways	I:C3271892
,	O
resulting	O
in	O
the	O
production	O
of	O
IL	O
-	I:C0021753
1	I:C0021753
β	I:C0021753
via	O
the	O
activation	O
of	O
caspase	O
-	I:C0534519
1	I:C0534519
upon	O
assembly	O
of	I:C3272079
the	I:C3272079
node	I:C3272079
-	I:C3272079
like	I:C3272079
receptor	I:C3272079
protein	I:C3272079
3	I:C3272079
(	I:C3272079
NLRP3	I:C3272079
)	I:C3272079
inflammasome	I:C3272079
.	O

Infection	O
of	O
various	O
cells	B:C0007634
with	O
Theiler	O
's	I:C0206425
murine	I:C0206425
encephalomyelitis	I:C0206425
virus	I:C0206425
(	O
Theiler	O
's	I:C0206425
murine	I:C0206425
encephalomyelitis	I:C0206425
virus	I:C0206425
)	O
activates	O
the	O
TLR	O
-	O
and	O
melanoma	O
differentiation	I:C3271892
-	I:C3271892
associated	I:C3271892
gene	I:C3271892
5	I:C3271892
(	I:C3271892
MDA5	I:C3271892
)	I:C3271892
-	I:C3271892
dependent	I:C3271892
pathways	I:C3271892
,	O
resulting	O
in	O
the	O
production	O
of	O
IL	O
-	I:C0021753
1	I:C0021753
β	I:C0021753
via	O
the	O
activation	O
of	O
caspase	O
-	I:C0534519
1	I:C0534519
upon	O
assembly	O
of	I:C3272079
the	I:C3272079
node	I:C3272079
-	I:C3272079
like	I:C3272079
receptor	I:C3272079
protein	I:C3272079
3	I:C3272079
(	I:C3272079
NLRP3	I:C3272079
)	I:C3272079
inflammasome	I:C3272079
.	O

Infection	O
of	O
various	O
cells	O
with	O
Theiler	B:C0206425
's	I:C0206425
murine	I:C0206425
encephalomyelitis	I:C0206425
virus	I:C0206425
(	O
Theiler	O
's	I:C0206425
murine	I:C0206425
encephalomyelitis	I:C0206425
virus	I:C0206425
)	O
activates	O
the	O
TLR	O
-	O
and	O
melanoma	O
differentiation	I:C3271892
-	I:C3271892
associated	I:C3271892
gene	I:C3271892
5	I:C3271892
(	I:C3271892
MDA5	I:C3271892
)	I:C3271892
-	I:C3271892
dependent	I:C3271892
pathways	I:C3271892
,	O
resulting	O
in	O
the	O
production	O
of	O
IL	O
-	I:C0021753
1	I:C0021753
β	I:C0021753
via	O
the	O
activation	O
of	O
caspase	O
-	I:C0534519
1	I:C0534519
upon	O
assembly	O
of	I:C3272079
the	I:C3272079
node	I:C3272079
-	I:C3272079
like	I:C3272079
receptor	I:C3272079
protein	I:C3272079
3	I:C3272079
(	I:C3272079
NLRP3	I:C3272079
)	I:C3272079
inflammasome	I:C3272079
.	O

Infection	O
of	O
various	O
cells	O
with	O
Theiler	O
's	I:C0206425
murine	I:C0206425
encephalomyelitis	I:C0206425
virus	I:C0206425
(	O
Theiler	B:C0206425
's	I:C0206425
murine	I:C0206425
encephalomyelitis	I:C0206425
virus	I:C0206425
)	O
activates	O
the	O
TLR	O
-	O
and	O
melanoma	O
differentiation	I:C3271892
-	I:C3271892
associated	I:C3271892
gene	I:C3271892
5	I:C3271892
(	I:C3271892
MDA5	I:C3271892
)	I:C3271892
-	I:C3271892
dependent	I:C3271892
pathways	I:C3271892
,	O
resulting	O
in	O
the	O
production	O
of	O
IL	O
-	I:C0021753
1	I:C0021753
β	I:C0021753
via	O
the	O
activation	O
of	O
caspase	O
-	I:C0534519
1	I:C0534519
upon	O
assembly	O
of	I:C3272079
the	I:C3272079
node	I:C3272079
-	I:C3272079
like	I:C3272079
receptor	I:C3272079
protein	I:C3272079
3	I:C3272079
(	I:C3272079
NLRP3	I:C3272079
)	I:C3272079
inflammasome	I:C3272079
.	O

Infection	O
of	O
various	O
cells	O
with	O
Theiler	O
's	I:C0206425
murine	I:C0206425
encephalomyelitis	I:C0206425
virus	I:C0206425
(	O
Theiler	O
's	I:C0206425
murine	I:C0206425
encephalomyelitis	I:C0206425
virus	I:C0206425
)	O
activates	B:C1148560
the	O
TLR	O
-	O
and	O
melanoma	O
differentiation	I:C3271892
-	I:C3271892
associated	I:C3271892
gene	I:C3271892
5	I:C3271892
(	I:C3271892
MDA5	I:C3271892
)	I:C3271892
-	I:C3271892
dependent	I:C3271892
pathways	I:C3271892
,	O
resulting	O
in	O
the	O
production	O
of	O
IL	O
-	I:C0021753
1	I:C0021753
β	I:C0021753
via	O
the	O
activation	O
of	O
caspase	O
-	I:C0534519
1	I:C0534519
upon	O
assembly	O
of	I:C3272079
the	I:C3272079
node	I:C3272079
-	I:C3272079
like	I:C3272079
receptor	I:C3272079
protein	I:C3272079
3	I:C3272079
(	I:C3272079
NLRP3	I:C3272079
)	I:C3272079
inflammasome	I:C3272079
.	O

Infection	O
of	O
various	O
cells	O
with	O
Theiler	O
's	I:C0206425
murine	I:C0206425
encephalomyelitis	I:C0206425
virus	I:C0206425
(	O
Theiler	O
's	I:C0206425
murine	I:C0206425
encephalomyelitis	I:C0206425
virus	I:C0206425
)	O
activates	O
the	O
TLR	B:C0670896
-	O
and	O
melanoma	O
differentiation	I:C3271892
-	I:C3271892
associated	I:C3271892
gene	I:C3271892
5	I:C3271892
(	I:C3271892
MDA5	I:C3271892
)	I:C3271892
-	I:C3271892
dependent	I:C3271892
pathways	I:C3271892
,	O
resulting	O
in	O
the	O
production	O
of	O
IL	O
-	I:C0021753
1	I:C0021753
β	I:C0021753
via	O
the	O
activation	O
of	O
caspase	O
-	I:C0534519
1	I:C0534519
upon	O
assembly	O
of	I:C3272079
the	I:C3272079
node	I:C3272079
-	I:C3272079
like	I:C3272079
receptor	I:C3272079
protein	I:C3272079
3	I:C3272079
(	I:C3272079
NLRP3	I:C3272079
)	I:C3272079
inflammasome	I:C3272079
.	O

Infection	O
of	O
various	O
cells	O
with	O
Theiler	O
's	I:C0206425
murine	I:C0206425
encephalomyelitis	I:C0206425
virus	I:C0206425
(	O
Theiler	O
's	I:C0206425
murine	I:C0206425
encephalomyelitis	I:C0206425
virus	I:C0206425
)	O
activates	O
the	O
TLR	O
-	O
and	O
melanoma	B:C3271892
differentiation	I:C3271892
-	I:C3271892
associated	I:C3271892
gene	I:C3271892
5	I:C3271892
(	I:C3271892
MDA5	I:C3271892
)	I:C3271892
-	I:C3271892
dependent	I:C3271892
pathways	I:C3271892
,	O
resulting	O
in	O
the	O
production	O
of	O
IL	O
-	I:C0021753
1	I:C0021753
β	I:C0021753
via	O
the	O
activation	O
of	O
caspase	O
-	I:C0534519
1	I:C0534519
upon	O
assembly	O
of	I:C3272079
the	I:C3272079
node	I:C3272079
-	I:C3272079
like	I:C3272079
receptor	I:C3272079
protein	I:C3272079
3	I:C3272079
(	I:C3272079
NLRP3	I:C3272079
)	I:C3272079
inflammasome	I:C3272079
.	O

Infection	O
of	O
various	O
cells	O
with	O
Theiler	O
's	I:C0206425
murine	I:C0206425
encephalomyelitis	I:C0206425
virus	I:C0206425
(	O
Theiler	O
's	I:C0206425
murine	I:C0206425
encephalomyelitis	I:C0206425
virus	I:C0206425
)	O
activates	O
the	O
TLR	O
-	O
and	O
melanoma	O
differentiation	I:C3271892
-	I:C3271892
associated	I:C3271892
gene	I:C3271892
5	I:C3271892
(	I:C3271892
MDA5	I:C3271892
)	I:C3271892
-	I:C3271892
dependent	I:C3271892
pathways	I:C3271892
,	O
resulting	O
in	O
the	O
production	B:C0007613
of	O
IL	O
-	I:C0021753
1	I:C0021753
β	I:C0021753
via	O
the	O
activation	O
of	O
caspase	O
-	I:C0534519
1	I:C0534519
upon	O
assembly	O
of	I:C3272079
the	I:C3272079
node	I:C3272079
-	I:C3272079
like	I:C3272079
receptor	I:C3272079
protein	I:C3272079
3	I:C3272079
(	I:C3272079
NLRP3	I:C3272079
)	I:C3272079
inflammasome	I:C3272079
.	O

Infection	O
of	O
various	O
cells	O
with	O
Theiler	O
's	I:C0206425
murine	I:C0206425
encephalomyelitis	I:C0206425
virus	I:C0206425
(	O
Theiler	O
's	I:C0206425
murine	I:C0206425
encephalomyelitis	I:C0206425
virus	I:C0206425
)	O
activates	O
the	O
TLR	O
-	O
and	O
melanoma	O
differentiation	I:C3271892
-	I:C3271892
associated	I:C3271892
gene	I:C3271892
5	I:C3271892
(	I:C3271892
MDA5	I:C3271892
)	I:C3271892
-	I:C3271892
dependent	I:C3271892
pathways	I:C3271892
,	O
resulting	O
in	O
the	O
production	O
of	O
IL	B:C0021753
-	I:C0021753
1	I:C0021753
β	I:C0021753
via	O
the	O
activation	O
of	O
caspase	O
-	I:C0534519
1	I:C0534519
upon	O
assembly	O
of	I:C3272079
the	I:C3272079
node	I:C3272079
-	I:C3272079
like	I:C3272079
receptor	I:C3272079
protein	I:C3272079
3	I:C3272079
(	I:C3272079
NLRP3	I:C3272079
)	I:C3272079
inflammasome	I:C3272079
.	O

Infection	O
of	O
various	O
cells	O
with	O
Theiler	O
's	I:C0206425
murine	I:C0206425
encephalomyelitis	I:C0206425
virus	I:C0206425
(	O
Theiler	O
's	I:C0206425
murine	I:C0206425
encephalomyelitis	I:C0206425
virus	I:C0206425
)	O
activates	O
the	O
TLR	O
-	O
and	O
melanoma	O
differentiation	I:C3271892
-	I:C3271892
associated	I:C3271892
gene	I:C3271892
5	I:C3271892
(	I:C3271892
MDA5	I:C3271892
)	I:C3271892
-	I:C3271892
dependent	I:C3271892
pathways	I:C3271892
,	O
resulting	O
in	O
the	O
production	O
of	O
IL	O
-	I:C0021753
1	I:C0021753
β	I:C0021753
via	O
the	O
activation	B:C0014429
of	O
caspase	O
-	I:C0534519
1	I:C0534519
upon	O
assembly	O
of	I:C3272079
the	I:C3272079
node	I:C3272079
-	I:C3272079
like	I:C3272079
receptor	I:C3272079
protein	I:C3272079
3	I:C3272079
(	I:C3272079
NLRP3	I:C3272079
)	I:C3272079
inflammasome	I:C3272079
.	O

Infection	O
of	O
various	O
cells	O
with	O
Theiler	O
's	I:C0206425
murine	I:C0206425
encephalomyelitis	I:C0206425
virus	I:C0206425
(	O
Theiler	O
's	I:C0206425
murine	I:C0206425
encephalomyelitis	I:C0206425
virus	I:C0206425
)	O
activates	O
the	O
TLR	O
-	O
and	O
melanoma	O
differentiation	I:C3271892
-	I:C3271892
associated	I:C3271892
gene	I:C3271892
5	I:C3271892
(	I:C3271892
MDA5	I:C3271892
)	I:C3271892
-	I:C3271892
dependent	I:C3271892
pathways	I:C3271892
,	O
resulting	O
in	O
the	O
production	O
of	O
IL	O
-	I:C0021753
1	I:C0021753
β	I:C0021753
via	O
the	O
activation	O
of	O
caspase	B:C0534519
-	I:C0534519
1	I:C0534519
upon	O
assembly	O
of	I:C3272079
the	I:C3272079
node	I:C3272079
-	I:C3272079
like	I:C3272079
receptor	I:C3272079
protein	I:C3272079
3	I:C3272079
(	I:C3272079
NLRP3	I:C3272079
)	I:C3272079
inflammasome	I:C3272079
.	O

Infection	O
of	O
various	O
cells	O
with	O
Theiler	O
's	I:C0206425
murine	I:C0206425
encephalomyelitis	I:C0206425
virus	I:C0206425
(	O
Theiler	O
's	I:C0206425
murine	I:C0206425
encephalomyelitis	I:C0206425
virus	I:C0206425
)	O
activates	O
the	O
TLR	O
-	O
and	O
melanoma	O
differentiation	I:C3271892
-	I:C3271892
associated	I:C3271892
gene	I:C3271892
5	I:C3271892
(	I:C3271892
MDA5	I:C3271892
)	I:C3271892
-	I:C3271892
dependent	I:C3271892
pathways	I:C3271892
,	O
resulting	O
in	O
the	O
production	O
of	O
IL	O
-	I:C0021753
1	I:C0021753
β	I:C0021753
via	O
the	O
activation	O
of	O
caspase	O
-	I:C0534519
1	I:C0534519
upon	O
assembly	B:C3272079
of	I:C3272079
the	I:C3272079
node	I:C3272079
-	I:C3272079
like	I:C3272079
receptor	I:C3272079
protein	I:C3272079
3	I:C3272079
(	I:C3272079
NLRP3	I:C3272079
)	I:C3272079
inflammasome	I:C3272079
.	O

The	O
role	O
of	O
IL	B:C0021753
-	I:C0021753
1	I:C0021753
β	I:C0021753
in	O
the	O
pathogenesis	O
of	O
Theiler	O
's	I:C0206425
murine	I:C0206425
encephalomyelitis	I:C0206425
virus	I:C0206425
-	O
induced	O
demyelinating	O
disease	I:C0011303
was	O
previously	O
investigated	O
.	O

The	O
role	O
of	O
IL	O
-	I:C0021753
1	I:C0021753
β	I:C0021753
in	O
the	O
pathogenesis	B:C0699748
of	O
Theiler	O
's	I:C0206425
murine	I:C0206425
encephalomyelitis	I:C0206425
virus	I:C0206425
-	O
induced	O
demyelinating	O
disease	I:C0011303
was	O
previously	O
investigated	O
.	O

The	O
role	O
of	O
IL	O
-	I:C0021753
1	I:C0021753
β	I:C0021753
in	O
the	O
pathogenesis	O
of	O
Theiler	B:C0206425
's	I:C0206425
murine	I:C0206425
encephalomyelitis	I:C0206425
virus	I:C0206425
-	O
induced	O
demyelinating	O
disease	I:C0011303
was	O
previously	O
investigated	O
.	O

The	O
role	O
of	O
IL	O
-	I:C0021753
1	I:C0021753
β	I:C0021753
in	O
the	O
pathogenesis	O
of	O
Theiler	O
's	I:C0206425
murine	I:C0206425
encephalomyelitis	I:C0206425
virus	I:C0206425
-	O
induced	O
demyelinating	B:C0011303
disease	I:C0011303
was	O
previously	O
investigated	O
.	O

However	O
,	O
the	O
signaling	B:C0037083
effects	O
of	O
prostaglandin	O
E2	I:C3813211
(	O
prostaglandin	O
E2	I:C3813211
)	O
downstream	O
of	O
the	O
NLRP3	O
inflammasome	I:C3156614
on	O
the	O
immune	O
responses	I:C0301872
to	O
viral	O
determinants	O
and	O
the	O
pathogenesis	O
of	O
demyelinating	O
disease	I:C0011303
are	O
unknown	O
.	O

However	O
,	O
the	O
signaling	O
effects	O
of	O
prostaglandin	B:C3813211
E2	I:C3813211
(	O
prostaglandin	O
E2	I:C3813211
)	O
downstream	O
of	O
the	O
NLRP3	O
inflammasome	I:C3156614
on	O
the	O
immune	O
responses	I:C0301872
to	O
viral	O
determinants	O
and	O
the	O
pathogenesis	O
of	O
demyelinating	O
disease	I:C0011303
are	O
unknown	O
.	O

However	O
,	O
the	O
signaling	O
effects	O
of	O
prostaglandin	O
E2	I:C3813211
(	O
prostaglandin	B:C3813211
E2	I:C3813211
)	O
downstream	O
of	O
the	O
NLRP3	O
inflammasome	I:C3156614
on	O
the	O
immune	O
responses	I:C0301872
to	O
viral	O
determinants	O
and	O
the	O
pathogenesis	O
of	O
demyelinating	O
disease	I:C0011303
are	O
unknown	O
.	O

However	O
,	O
the	O
signaling	O
effects	O
of	O
prostaglandin	O
E2	I:C3813211
(	O
prostaglandin	O
E2	I:C3813211
)	O
downstream	B:C0522506
of	O
the	O
NLRP3	O
inflammasome	I:C3156614
on	O
the	O
immune	O
responses	I:C0301872
to	O
viral	O
determinants	O
and	O
the	O
pathogenesis	O
of	O
demyelinating	O
disease	I:C0011303
are	O
unknown	O
.	O

However	O
,	O
the	O
signaling	O
effects	O
of	O
prostaglandin	O
E2	I:C3813211
(	O
prostaglandin	O
E2	I:C3813211
)	O
downstream	O
of	O
the	O
NLRP3	B:C3156614
inflammasome	I:C3156614
on	O
the	O
immune	O
responses	I:C0301872
to	O
viral	O
determinants	O
and	O
the	O
pathogenesis	O
of	O
demyelinating	O
disease	I:C0011303
are	O
unknown	O
.	O

However	O
,	O
the	O
signaling	O
effects	O
of	O
prostaglandin	O
E2	I:C3813211
(	O
prostaglandin	O
E2	I:C3813211
)	O
downstream	O
of	O
the	O
NLRP3	O
inflammasome	I:C3156614
on	O
the	O
immune	B:C0301872
responses	I:C0301872
to	O
viral	O
determinants	O
and	O
the	O
pathogenesis	O
of	O
demyelinating	O
disease	I:C0011303
are	O
unknown	O
.	O

However	O
,	O
the	O
signaling	O
effects	O
of	O
prostaglandin	O
E2	I:C3813211
(	O
prostaglandin	O
E2	I:C3813211
)	O
downstream	O
of	O
the	O
NLRP3	O
inflammasome	I:C3156614
on	O
the	O
immune	O
responses	I:C0301872
to	O
viral	B:C0042776
determinants	O
and	O
the	O
pathogenesis	O
of	O
demyelinating	O
disease	I:C0011303
are	O
unknown	O
.	O

However	O
,	O
the	O
signaling	O
effects	O
of	O
prostaglandin	O
E2	I:C3813211
(	O
prostaglandin	O
E2	I:C3813211
)	O
downstream	O
of	O
the	O
NLRP3	O
inflammasome	I:C3156614
on	O
the	O
immune	O
responses	I:C0301872
to	O
viral	O
determinants	B:C0003316
and	O
the	O
pathogenesis	O
of	O
demyelinating	O
disease	I:C0011303
are	O
unknown	O
.	O

However	O
,	O
the	O
signaling	O
effects	O
of	O
prostaglandin	O
E2	I:C3813211
(	O
prostaglandin	O
E2	I:C3813211
)	O
downstream	O
of	O
the	O
NLRP3	O
inflammasome	I:C3156614
on	O
the	O
immune	O
responses	I:C0301872
to	O
viral	O
determinants	O
and	O
the	O
pathogenesis	B:C0699748
of	O
demyelinating	O
disease	I:C0011303
are	O
unknown	O
.	O

However	O
,	O
the	O
signaling	O
effects	O
of	O
prostaglandin	O
E2	I:C3813211
(	O
prostaglandin	O
E2	I:C3813211
)	O
downstream	O
of	O
the	O
NLRP3	O
inflammasome	I:C3156614
on	O
the	O
immune	O
responses	I:C0301872
to	O
viral	O
determinants	O
and	O
the	O
pathogenesis	O
of	O
demyelinating	B:C0011303
disease	I:C0011303
are	O
unknown	O
.	O

In	O
this	O
study	B:C2603343
,	O
we	O
investigated	O
the	O
levels	O
of	O
intermediate	O
molecules	O
leading	O
to	O
prostaglandin	O
E2	I:C3813211
signaling	O
and	O
the	O
effects	O
of	O
blocking	O
prostaglandin	O
E2	I:C3813211
signaling	O
on	O
the	O
immune	O
response	I:C0301872
to	O
Theiler	O
's	I:C0206425
murine	I:C0206425
encephalomyelitis	I:C0206425
virus	I:C0206425
infection	O
,	O
viral	O
persistence	O
and	O
the	O
development	O
of	O
demyelinating	O
disease	I:C0011303
.	O

In	O
this	O
study	O
,	O
we	O
investigated	O
the	O
levels	O
of	O
intermediate	B:C0205103
molecules	O
leading	O
to	O
prostaglandin	O
E2	I:C3813211
signaling	O
and	O
the	O
effects	O
of	O
blocking	O
prostaglandin	O
E2	I:C3813211
signaling	O
on	O
the	O
immune	O
response	I:C0301872
to	O
Theiler	O
's	I:C0206425
murine	I:C0206425
encephalomyelitis	I:C0206425
virus	I:C0206425
infection	O
,	O
viral	O
persistence	O
and	O
the	O
development	O
of	O
demyelinating	O
disease	I:C0011303
.	O

In	O
this	O
study	O
,	O
we	O
investigated	O
the	O
levels	O
of	O
intermediate	O
molecules	O
leading	O
to	O
prostaglandin	B:C3813211
E2	I:C3813211
signaling	O
and	O
the	O
effects	O
of	O
blocking	O
prostaglandin	O
E2	I:C3813211
signaling	O
on	O
the	O
immune	O
response	I:C0301872
to	O
Theiler	O
's	I:C0206425
murine	I:C0206425
encephalomyelitis	I:C0206425
virus	I:C0206425
infection	O
,	O
viral	O
persistence	O
and	O
the	O
development	O
of	O
demyelinating	O
disease	I:C0011303
.	O

In	O
this	O
study	O
,	O
we	O
investigated	O
the	O
levels	O
of	O
intermediate	O
molecules	O
leading	O
to	O
prostaglandin	O
E2	I:C3813211
signaling	B:C0037083
and	O
the	O
effects	O
of	O
blocking	O
prostaglandin	O
E2	I:C3813211
signaling	O
on	O
the	O
immune	O
response	I:C0301872
to	O
Theiler	O
's	I:C0206425
murine	I:C0206425
encephalomyelitis	I:C0206425
virus	I:C0206425
infection	O
,	O
viral	O
persistence	O
and	O
the	O
development	O
of	O
demyelinating	O
disease	I:C0011303
.	O

In	O
this	O
study	O
,	O
we	O
investigated	O
the	O
levels	O
of	O
intermediate	O
molecules	O
leading	O
to	O
prostaglandin	O
E2	I:C3813211
signaling	O
and	O
the	O
effects	O
of	O
blocking	O
prostaglandin	B:C3813211
E2	I:C3813211
signaling	O
on	O
the	O
immune	O
response	I:C0301872
to	O
Theiler	O
's	I:C0206425
murine	I:C0206425
encephalomyelitis	I:C0206425
virus	I:C0206425
infection	O
,	O
viral	O
persistence	O
and	O
the	O
development	O
of	O
demyelinating	O
disease	I:C0011303
.	O

In	O
this	O
study	O
,	O
we	O
investigated	O
the	O
levels	O
of	O
intermediate	O
molecules	O
leading	O
to	O
prostaglandin	O
E2	I:C3813211
signaling	O
and	O
the	O
effects	O
of	O
blocking	O
prostaglandin	O
E2	I:C3813211
signaling	B:C0037083
on	O
the	O
immune	O
response	I:C0301872
to	O
Theiler	O
's	I:C0206425
murine	I:C0206425
encephalomyelitis	I:C0206425
virus	I:C0206425
infection	O
,	O
viral	O
persistence	O
and	O
the	O
development	O
of	O
demyelinating	O
disease	I:C0011303
.	O

In	O
this	O
study	O
,	O
we	O
investigated	O
the	O
levels	O
of	O
intermediate	O
molecules	O
leading	O
to	O
prostaglandin	O
E2	I:C3813211
signaling	O
and	O
the	O
effects	O
of	O
blocking	O
prostaglandin	O
E2	I:C3813211
signaling	O
on	O
the	O
immune	B:C0301872
response	I:C0301872
to	O
Theiler	O
's	I:C0206425
murine	I:C0206425
encephalomyelitis	I:C0206425
virus	I:C0206425
infection	O
,	O
viral	O
persistence	O
and	O
the	O
development	O
of	O
demyelinating	O
disease	I:C0011303
.	O

In	O
this	O
study	O
,	O
we	O
investigated	O
the	O
levels	O
of	O
intermediate	O
molecules	O
leading	O
to	O
prostaglandin	O
E2	I:C3813211
signaling	O
and	O
the	O
effects	O
of	O
blocking	O
prostaglandin	O
E2	I:C3813211
signaling	O
on	O
the	O
immune	O
response	I:C0301872
to	O
Theiler	B:C0206425
's	I:C0206425
murine	I:C0206425
encephalomyelitis	I:C0206425
virus	I:C0206425
infection	O
,	O
viral	O
persistence	O
and	O
the	O
development	O
of	O
demyelinating	O
disease	I:C0011303
.	O

In	O
this	O
study	O
,	O
we	O
investigated	O
the	O
levels	O
of	O
intermediate	O
molecules	O
leading	O
to	O
prostaglandin	O
E2	I:C3813211
signaling	O
and	O
the	O
effects	O
of	O
blocking	O
prostaglandin	O
E2	I:C3813211
signaling	O
on	O
the	O
immune	O
response	I:C0301872
to	O
Theiler	O
's	I:C0206425
murine	I:C0206425
encephalomyelitis	I:C0206425
virus	I:C0206425
infection	B:C3714514
,	O
viral	O
persistence	O
and	O
the	O
development	O
of	O
demyelinating	O
disease	I:C0011303
.	O

In	O
this	O
study	O
,	O
we	O
investigated	O
the	O
levels	O
of	O
intermediate	O
molecules	O
leading	O
to	O
prostaglandin	O
E2	I:C3813211
signaling	O
and	O
the	O
effects	O
of	O
blocking	O
prostaglandin	O
E2	I:C3813211
signaling	O
on	O
the	O
immune	O
response	I:C0301872
to	O
Theiler	O
's	I:C0206425
murine	I:C0206425
encephalomyelitis	I:C0206425
virus	I:C0206425
infection	O
,	O
viral	B:C0042776
persistence	O
and	O
the	O
development	O
of	O
demyelinating	O
disease	I:C0011303
.	O

In	O
this	O
study	O
,	O
we	O
investigated	O
the	O
levels	O
of	O
intermediate	O
molecules	O
leading	O
to	O
prostaglandin	O
E2	I:C3813211
signaling	O
and	O
the	O
effects	O
of	O
blocking	O
prostaglandin	O
E2	I:C3813211
signaling	O
on	O
the	O
immune	O
response	I:C0301872
to	O
Theiler	O
's	I:C0206425
murine	I:C0206425
encephalomyelitis	I:C0206425
virus	I:C0206425
infection	O
,	O
viral	O
persistence	B:C0243095
and	O
the	O
development	O
of	O
demyelinating	O
disease	I:C0011303
.	O

In	O
this	O
study	O
,	O
we	O
investigated	O
the	O
levels	O
of	O
intermediate	O
molecules	O
leading	O
to	O
prostaglandin	O
E2	I:C3813211
signaling	O
and	O
the	O
effects	O
of	O
blocking	O
prostaglandin	O
E2	I:C3813211
signaling	O
on	O
the	O
immune	O
response	I:C0301872
to	O
Theiler	O
's	I:C0206425
murine	I:C0206425
encephalomyelitis	I:C0206425
virus	I:C0206425
infection	O
,	O
viral	O
persistence	O
and	O
the	O
development	O
of	O
demyelinating	B:C0011303
disease	I:C0011303
.	O

We	O
demonstrate	O
here	O
that	O
Theiler	B:C0206425
's	I:C0206425
murine	I:C0206425
encephalomyelitis	I:C0206425
virus	I:C0206425
infection	O
activates	O
the	O
NLRP3	O
inflammasome	I:C3156614
and	O
prostaglandin	O
E2	I:C3813211
signaling	O
much	O
more	O
vigorously	O
in	O
dendritic	O
cells	I:C0011306
(	O
dendritic	O
cells	I:C0011306
)	O
and	O
CD11b	O
+	I:C1267867
cells	I:C1267867
from	O
susceptible	O
SJL	O
mice	I:C1519146
than	O
in	O
cells	O
from	O
resistant	O
B6	O
mice	I:C0025929
.	O

We	O
demonstrate	O
here	O
that	O
Theiler	O
's	I:C0206425
murine	I:C0206425
encephalomyelitis	I:C0206425
virus	I:C0206425
infection	B:C3714514
activates	O
the	O
NLRP3	O
inflammasome	I:C3156614
and	O
prostaglandin	O
E2	I:C3813211
signaling	O
much	O
more	O
vigorously	O
in	O
dendritic	O
cells	I:C0011306
(	O
dendritic	O
cells	I:C0011306
)	O
and	O
CD11b	O
+	I:C1267867
cells	I:C1267867
from	O
susceptible	O
SJL	O
mice	I:C1519146
than	O
in	O
cells	O
from	O
resistant	O
B6	O
mice	I:C0025929
.	O

We	O
demonstrate	O
here	O
that	O
Theiler	O
's	I:C0206425
murine	I:C0206425
encephalomyelitis	I:C0206425
virus	I:C0206425
infection	O
activates	B:C1148560
the	O
NLRP3	O
inflammasome	I:C3156614
and	O
prostaglandin	O
E2	I:C3813211
signaling	O
much	O
more	O
vigorously	O
in	O
dendritic	O
cells	I:C0011306
(	O
dendritic	O
cells	I:C0011306
)	O
and	O
CD11b	O
+	I:C1267867
cells	I:C1267867
from	O
susceptible	O
SJL	O
mice	I:C1519146
than	O
in	O
cells	O
from	O
resistant	O
B6	O
mice	I:C0025929
.	O

We	O
demonstrate	O
here	O
that	O
Theiler	O
's	I:C0206425
murine	I:C0206425
encephalomyelitis	I:C0206425
virus	I:C0206425
infection	O
activates	O
the	O
NLRP3	B:C3156614
inflammasome	I:C3156614
and	O
prostaglandin	O
E2	I:C3813211
signaling	O
much	O
more	O
vigorously	O
in	O
dendritic	O
cells	I:C0011306
(	O
dendritic	O
cells	I:C0011306
)	O
and	O
CD11b	O
+	I:C1267867
cells	I:C1267867
from	O
susceptible	O
SJL	O
mice	I:C1519146
than	O
in	O
cells	O
from	O
resistant	O
B6	O
mice	I:C0025929
.	O

We	O
demonstrate	O
here	O
that	O
Theiler	O
's	I:C0206425
murine	I:C0206425
encephalomyelitis	I:C0206425
virus	I:C0206425
infection	O
activates	O
the	O
NLRP3	O
inflammasome	I:C3156614
and	O
prostaglandin	B:C3813211
E2	I:C3813211
signaling	O
much	O
more	O
vigorously	O
in	O
dendritic	O
cells	I:C0011306
(	O
dendritic	O
cells	I:C0011306
)	O
and	O
CD11b	O
+	I:C1267867
cells	I:C1267867
from	O
susceptible	O
SJL	O
mice	I:C1519146
than	O
in	O
cells	O
from	O
resistant	O
B6	O
mice	I:C0025929
.	O

We	O
demonstrate	O
here	O
that	O
Theiler	O
's	I:C0206425
murine	I:C0206425
encephalomyelitis	I:C0206425
virus	I:C0206425
infection	O
activates	O
the	O
NLRP3	O
inflammasome	I:C3156614
and	O
prostaglandin	O
E2	I:C3813211
signaling	B:C0037083
much	O
more	O
vigorously	O
in	O
dendritic	O
cells	I:C0011306
(	O
dendritic	O
cells	I:C0011306
)	O
and	O
CD11b	O
+	I:C1267867
cells	I:C1267867
from	O
susceptible	O
SJL	O
mice	I:C1519146
than	O
in	O
cells	O
from	O
resistant	O
B6	O
mice	I:C0025929
.	O

We	O
demonstrate	O
here	O
that	O
Theiler	O
's	I:C0206425
murine	I:C0206425
encephalomyelitis	I:C0206425
virus	I:C0206425
infection	O
activates	O
the	O
NLRP3	O
inflammasome	I:C3156614
and	O
prostaglandin	O
E2	I:C3813211
signaling	O
much	O
more	O
vigorously	O
in	O
dendritic	B:C0011306
cells	I:C0011306
(	O
dendritic	O
cells	I:C0011306
)	O
and	O
CD11b	O
+	I:C1267867
cells	I:C1267867
from	O
susceptible	O
SJL	O
mice	I:C1519146
than	O
in	O
cells	O
from	O
resistant	O
B6	O
mice	I:C0025929
.	O

We	O
demonstrate	O
here	O
that	O
Theiler	O
's	I:C0206425
murine	I:C0206425
encephalomyelitis	I:C0206425
virus	I:C0206425
infection	O
activates	O
the	O
NLRP3	O
inflammasome	I:C3156614
and	O
prostaglandin	O
E2	I:C3813211
signaling	O
much	O
more	O
vigorously	O
in	O
dendritic	O
cells	I:C0011306
(	O
dendritic	B:C0011306
cells	I:C0011306
)	O
and	O
CD11b	O
+	I:C1267867
cells	I:C1267867
from	O
susceptible	O
SJL	O
mice	I:C1519146
than	O
in	O
cells	O
from	O
resistant	O
B6	O
mice	I:C0025929
.	O

We	O
demonstrate	O
here	O
that	O
Theiler	O
's	I:C0206425
murine	I:C0206425
encephalomyelitis	I:C0206425
virus	I:C0206425
infection	O
activates	O
the	O
NLRP3	O
inflammasome	I:C3156614
and	O
prostaglandin	O
E2	I:C3813211
signaling	O
much	O
more	O
vigorously	O
in	O
dendritic	O
cells	I:C0011306
(	O
dendritic	O
cells	I:C0011306
)	O
and	O
CD11b	B:C1267867
+	I:C1267867
cells	I:C1267867
from	O
susceptible	O
SJL	O
mice	I:C1519146
than	O
in	O
cells	O
from	O
resistant	O
B6	O
mice	I:C0025929
.	O

We	O
demonstrate	O
here	O
that	O
Theiler	O
's	I:C0206425
murine	I:C0206425
encephalomyelitis	I:C0206425
virus	I:C0206425
infection	O
activates	O
the	O
NLRP3	O
inflammasome	I:C3156614
and	O
prostaglandin	O
E2	I:C3813211
signaling	O
much	O
more	O
vigorously	O
in	O
dendritic	O
cells	I:C0011306
(	O
dendritic	O
cells	I:C0011306
)	O
and	O
CD11b	O
+	I:C1267867
cells	I:C1267867
from	O
susceptible	O
SJL	B:C1519146
mice	I:C1519146
than	O
in	O
cells	O
from	O
resistant	O
B6	O
mice	I:C0025929
.	O

We	O
demonstrate	O
here	O
that	O
Theiler	O
's	I:C0206425
murine	I:C0206425
encephalomyelitis	I:C0206425
virus	I:C0206425
infection	O
activates	O
the	O
NLRP3	O
inflammasome	I:C3156614
and	O
prostaglandin	O
E2	I:C3813211
signaling	O
much	O
more	O
vigorously	O
in	O
dendritic	O
cells	I:C0011306
(	O
dendritic	O
cells	I:C0011306
)	O
and	O
CD11b	O
+	I:C1267867
cells	I:C1267867
from	O
susceptible	O
SJL	O
mice	I:C1519146
than	O
in	O
cells	B:C0007634
from	O
resistant	O
B6	O
mice	I:C0025929
.	O

We	O
demonstrate	O
here	O
that	O
Theiler	O
's	I:C0206425
murine	I:C0206425
encephalomyelitis	I:C0206425
virus	I:C0206425
infection	O
activates	O
the	O
NLRP3	O
inflammasome	I:C3156614
and	O
prostaglandin	O
E2	I:C3813211
signaling	O
much	O
more	O
vigorously	O
in	O
dendritic	O
cells	I:C0011306
(	O
dendritic	O
cells	I:C0011306
)	O
and	O
CD11b	O
+	I:C1267867
cells	I:C1267867
from	O
susceptible	O
SJL	O
mice	I:C1519146
than	O
in	O
cells	O
from	O
resistant	O
B6	B:C0025929
mice	I:C0025929
.	O

Inhibition	O
of	O
virus	B:C0206425
-	O
induced	O
prostaglandin	O
E2	I:C3813211
signaling	O
using	O
AH23848	O
resulted	O
in	O
decreased	O
pathogenesis	O
of	O
demyelinating	O
disease	I:C0011303
and	O
viral	O
loads	I:C0376705
in	O
the	O
central	O
nervous	I:C3714787
system	I:C3714787
(	O
central	O
nervous	I:C3714787
system	I:C3714787
)	O
.	O

Inhibition	O
of	O
virus	O
-	O
induced	O
prostaglandin	B:C3813211
E2	I:C3813211
signaling	O
using	O
AH23848	O
resulted	O
in	O
decreased	O
pathogenesis	O
of	O
demyelinating	O
disease	I:C0011303
and	O
viral	O
loads	I:C0376705
in	O
the	O
central	O
nervous	I:C3714787
system	I:C3714787
(	O
central	O
nervous	I:C3714787
system	I:C3714787
)	O
.	O

Inhibition	O
of	O
virus	O
-	O
induced	O
prostaglandin	O
E2	I:C3813211
signaling	B:C0037083
using	O
AH23848	O
resulted	O
in	O
decreased	O
pathogenesis	O
of	O
demyelinating	O
disease	I:C0011303
and	O
viral	O
loads	I:C0376705
in	O
the	O
central	O
nervous	I:C3714787
system	I:C3714787
(	O
central	O
nervous	I:C3714787
system	I:C3714787
)	O
.	O

Inhibition	O
of	O
virus	O
-	O
induced	O
prostaglandin	O
E2	I:C3813211
signaling	O
using	O
AH23848	B:C0051000
resulted	O
in	O
decreased	O
pathogenesis	O
of	O
demyelinating	O
disease	I:C0011303
and	O
viral	O
loads	I:C0376705
in	O
the	O
central	O
nervous	I:C3714787
system	I:C3714787
(	O
central	O
nervous	I:C3714787
system	I:C3714787
)	O
.	O

Inhibition	O
of	O
virus	O
-	O
induced	O
prostaglandin	O
E2	I:C3813211
signaling	O
using	O
AH23848	O
resulted	O
in	O
decreased	O
pathogenesis	B:C0699748
of	O
demyelinating	O
disease	I:C0011303
and	O
viral	O
loads	I:C0376705
in	O
the	O
central	O
nervous	I:C3714787
system	I:C3714787
(	O
central	O
nervous	I:C3714787
system	I:C3714787
)	O
.	O

Inhibition	O
of	O
virus	O
-	O
induced	O
prostaglandin	O
E2	I:C3813211
signaling	O
using	O
AH23848	O
resulted	O
in	O
decreased	O
pathogenesis	O
of	O
demyelinating	B:C0011303
disease	I:C0011303
and	O
viral	O
loads	I:C0376705
in	O
the	O
central	O
nervous	I:C3714787
system	I:C3714787
(	O
central	O
nervous	I:C3714787
system	I:C3714787
)	O
.	O

Inhibition	O
of	O
virus	O
-	O
induced	O
prostaglandin	O
E2	I:C3813211
signaling	O
using	O
AH23848	O
resulted	O
in	O
decreased	O
pathogenesis	O
of	O
demyelinating	O
disease	I:C0011303
and	O
viral	B:C0376705
loads	I:C0376705
in	O
the	O
central	O
nervous	I:C3714787
system	I:C3714787
(	O
central	O
nervous	I:C3714787
system	I:C3714787
)	O
.	O

Inhibition	O
of	O
virus	O
-	O
induced	O
prostaglandin	O
E2	I:C3813211
signaling	O
using	O
AH23848	O
resulted	O
in	O
decreased	O
pathogenesis	O
of	O
demyelinating	O
disease	I:C0011303
and	O
viral	O
loads	I:C0376705
in	O
the	O
central	B:C3714787
nervous	I:C3714787
system	I:C3714787
(	O
central	O
nervous	I:C3714787
system	I:C3714787
)	O
.	O

Inhibition	O
of	O
virus	O
-	O
induced	O
prostaglandin	O
E2	I:C3813211
signaling	O
using	O
AH23848	O
resulted	O
in	O
decreased	O
pathogenesis	O
of	O
demyelinating	O
disease	I:C0011303
and	O
viral	O
loads	I:C0376705
in	O
the	O
central	O
nervous	I:C3714787
system	I:C3714787
(	O
central	B:C3714787
nervous	I:C3714787
system	I:C3714787
)	O
.	O

In	O
addition	O
,	O
AH23848	B:C0051000
treatment	O
caused	O
the	O
elevation	O
of	O
protective	O
early	O
IFN	O
-γ	I:C0021745
-	O
producing	O
CD4	O
+	I:C0039215
and	O
CD8	O
+	I:C0242629

In	O
addition	O
,	O
AH23848	O
treatment	B:C0087111
caused	O
the	O
elevation	O
of	O
protective	O
early	O
IFN	O
-γ	I:C0021745
-	O
producing	O
CD4	O
+	I:C0039215
and	O
CD8	O
+	I:C0242629

In	O
addition	O
,	O
AH23848	O
treatment	O
caused	O
the	O
elevation	B:C0702240
of	O
protective	O
early	O
IFN	O
-γ	I:C0021745
-	O
producing	O
CD4	O
+	I:C0039215
and	O
CD8	O
+	I:C0242629

In	O
addition	O
,	O
AH23848	O
treatment	O
caused	O
the	O
elevation	O
of	O
protective	O
early	O
IFN	B:C0021745
-γ	I:C0021745
-	O
producing	O
CD4	O
+	I:C0039215
and	O
CD8	O
+	I:C0242629

In	O
addition	O
,	O
AH23848	O
treatment	O
caused	O
the	O
elevation	O
of	O
protective	O
early	O
IFN	O
-γ	I:C0021745
-	O
producing	B:C0007613
CD4	O
+	I:C0039215
and	O
CD8	O
+	I:C0242629

In	O
addition	O
,	O
AH23848	O
treatment	O
caused	O
the	O
elevation	O
of	O
protective	O
early	O
IFN	O
-γ	I:C0021745
-	O
producing	O
CD4	B:C0039215
+	I:C0039215
and	O
CD8	O
+	I:C0242629

In	O
addition	O
,	O
AH23848	O
treatment	O
caused	O
the	O
elevation	O
of	O
protective	O
early	O
IFN	O
-γ	I:C0021745
-	O
producing	O
CD4	O
+	I:C0039215
and	O
CD8	B:C0242629
+	I:C0242629

Because	O
the	O
levels	O
of	O
IFN	B:C0015980
-β	I:C0015980
were	O
lower	O
in	O
AH23848	O
-	O
treated	O
mice	O
but	O
the	O
level	O
of	O
IL	O
-	I:C0021760
6	I:C0021760
was	O
similar	O
,	O
over	O
-	I:C0007613
production	I:C0007613
of	O
pathogenic	O
IFN	O
-β	I:C0015980
was	O
modulated	O
and	O
the	O
generation	O
of	O
IFN	O
-γ	I:C0021745
-	O
producing	O
T	O
cell	I:C0039194
responses	O
was	O
enhanced	O
by	O
the	O
inhibition	O
of	O
prostaglandin	O
E2	I:C3813211
signaling	O
.	O

Because	O
the	O
levels	O
of	O
IFN	O
-β	I:C0015980
were	O
lower	O
in	O
AH23848	B:C0051000
-	O
treated	O
mice	O
but	O
the	O
level	O
of	O
IL	O
-	I:C0021760
6	I:C0021760
was	O
similar	O
,	O
over	O
-	I:C0007613
production	I:C0007613
of	O
pathogenic	O
IFN	O
-β	I:C0015980
was	O
modulated	O
and	O
the	O
generation	O
of	O
IFN	O
-γ	I:C0021745
-	O
producing	O
T	O
cell	I:C0039194
responses	O
was	O
enhanced	O
by	O
the	O
inhibition	O
of	O
prostaglandin	O
E2	I:C3813211
signaling	O
.	O

Because	O
the	O
levels	O
of	O
IFN	O
-β	I:C0015980
were	O
lower	O
in	O
AH23848	O
-	O
treated	O
mice	B:C0025929
but	O
the	O
level	O
of	O
IL	O
-	I:C0021760
6	I:C0021760
was	O
similar	O
,	O
over	O
-	I:C0007613
production	I:C0007613
of	O
pathogenic	O
IFN	O
-β	I:C0015980
was	O
modulated	O
and	O
the	O
generation	O
of	O
IFN	O
-γ	I:C0021745
-	O
producing	O
T	O
cell	I:C0039194
responses	O
was	O
enhanced	O
by	O
the	O
inhibition	O
of	O
prostaglandin	O
E2	I:C3813211
signaling	O
.	O

Because	O
the	O
levels	O
of	O
IFN	O
-β	I:C0015980
were	O
lower	O
in	O
AH23848	O
-	O
treated	O
mice	O
but	O
the	O
level	O
of	O
IL	B:C0021760
-	I:C0021760
6	I:C0021760
was	O
similar	O
,	O
over	O
-	I:C0007613
production	I:C0007613
of	O
pathogenic	O
IFN	O
-β	I:C0015980
was	O
modulated	O
and	O
the	O
generation	O
of	O
IFN	O
-γ	I:C0021745
-	O
producing	O
T	O
cell	I:C0039194
responses	O
was	O
enhanced	O
by	O
the	O
inhibition	O
of	O
prostaglandin	O
E2	I:C3813211
signaling	O
.	O

Because	O
the	O
levels	O
of	O
IFN	O
-β	I:C0015980
were	O
lower	O
in	O
AH23848	O
-	O
treated	O
mice	O
but	O
the	O
level	O
of	O
IL	O
-	I:C0021760
6	I:C0021760
was	O
similar	O
,	O
over	B:C0007613
-	I:C0007613
production	I:C0007613
of	O
pathogenic	O
IFN	O
-β	I:C0015980
was	O
modulated	O
and	O
the	O
generation	O
of	O
IFN	O
-γ	I:C0021745
-	O
producing	O
T	O
cell	I:C0039194
responses	O
was	O
enhanced	O
by	O
the	O
inhibition	O
of	O
prostaglandin	O
E2	I:C3813211
signaling	O
.	O

Because	O
the	O
levels	O
of	O
IFN	O
-β	I:C0015980
were	O
lower	O
in	O
AH23848	O
-	O
treated	O
mice	O
but	O
the	O
level	O
of	O
IL	O
-	I:C0021760
6	I:C0021760
was	O
similar	O
,	O
over	O
-	I:C0007613
production	I:C0007613
of	O
pathogenic	B:C3816499
IFN	O
-β	I:C0015980
was	O
modulated	O
and	O
the	O
generation	O
of	O
IFN	O
-γ	I:C0021745
-	O
producing	O
T	O
cell	I:C0039194
responses	O
was	O
enhanced	O
by	O
the	O
inhibition	O
of	O
prostaglandin	O
E2	I:C3813211
signaling	O
.	O

Because	O
the	O
levels	O
of	O
IFN	O
-β	I:C0015980
were	O
lower	O
in	O
AH23848	O
-	O
treated	O
mice	O
but	O
the	O
level	O
of	O
IL	O
-	I:C0021760
6	I:C0021760
was	O
similar	O
,	O
over	O
-	I:C0007613
production	I:C0007613
of	O
pathogenic	O
IFN	B:C0015980
-β	I:C0015980
was	O
modulated	O
and	O
the	O
generation	O
of	O
IFN	O
-γ	I:C0021745
-	O
producing	O
T	O
cell	I:C0039194
responses	O
was	O
enhanced	O
by	O
the	O
inhibition	O
of	O
prostaglandin	O
E2	I:C3813211
signaling	O
.	O

Because	O
the	O
levels	O
of	O
IFN	O
-β	I:C0015980
were	O
lower	O
in	O
AH23848	O
-	O
treated	O
mice	O
but	O
the	O
level	O
of	O
IL	O
-	I:C0021760
6	I:C0021760
was	O
similar	O
,	O
over	O
-	I:C0007613
production	I:C0007613
of	O
pathogenic	O
IFN	O
-β	I:C0015980
was	O
modulated	B:C0443264
and	O
the	O
generation	O
of	O
IFN	O
-γ	I:C0021745
-	O
producing	O
T	O
cell	I:C0039194
responses	O
was	O
enhanced	O
by	O
the	O
inhibition	O
of	O
prostaglandin	O
E2	I:C3813211
signaling	O
.	O

Because	O
the	O
levels	O
of	O
IFN	O
-β	I:C0015980
were	O
lower	O
in	O
AH23848	O
-	O
treated	O
mice	O
but	O
the	O
level	O
of	O
IL	O
-	I:C0021760
6	I:C0021760
was	O
similar	O
,	O
over	O
-	I:C0007613
production	I:C0007613
of	O
pathogenic	O
IFN	O
-β	I:C0015980
was	O
modulated	O
and	O
the	O
generation	O
of	O
IFN	B:C0021745
-γ	I:C0021745
-	O
producing	O
T	O
cell	I:C0039194
responses	O
was	O
enhanced	O
by	O
the	O
inhibition	O
of	O
prostaglandin	O
E2	I:C3813211
signaling	O
.	O

Because	O
the	O
levels	O
of	O
IFN	O
-β	I:C0015980
were	O
lower	O
in	O
AH23848	O
-	O
treated	O
mice	O
but	O
the	O
level	O
of	O
IL	O
-	I:C0021760
6	I:C0021760
was	O
similar	O
,	O
over	O
-	I:C0007613
production	I:C0007613
of	O
pathogenic	O
IFN	O
-β	I:C0015980
was	O
modulated	O
and	O
the	O
generation	O
of	O
IFN	O
-γ	I:C0021745
-	O
producing	B:C0007613
T	O
cell	I:C0039194
responses	O
was	O
enhanced	O
by	O
the	O
inhibition	O
of	O
prostaglandin	O
E2	I:C3813211
signaling	O
.	O

Because	O
the	O
levels	O
of	O
IFN	O
-β	I:C0015980
were	O
lower	O
in	O
AH23848	O
-	O
treated	O
mice	O
but	O
the	O
level	O
of	O
IL	O
-	I:C0021760
6	I:C0021760
was	O
similar	O
,	O
over	O
-	I:C0007613
production	I:C0007613
of	O
pathogenic	O
IFN	O
-β	I:C0015980
was	O
modulated	O
and	O
the	O
generation	O
of	O
IFN	O
-γ	I:C0021745
-	O
producing	O
T	B:C0039194
cell	I:C0039194
responses	O
was	O
enhanced	O
by	O
the	O
inhibition	O
of	O
prostaglandin	O
E2	I:C3813211
signaling	O
.	O

Because	O
the	O
levels	O
of	O
IFN	O
-β	I:C0015980
were	O
lower	O
in	O
AH23848	O
-	O
treated	O
mice	O
but	O
the	O
level	O
of	O
IL	O
-	I:C0021760
6	I:C0021760
was	O
similar	O
,	O
over	O
-	I:C0007613
production	I:C0007613
of	O
pathogenic	O
IFN	O
-β	I:C0015980
was	O
modulated	O
and	O
the	O
generation	O
of	O
IFN	O
-γ	I:C0021745
-	O
producing	O
T	O
cell	I:C0039194
responses	O
was	O
enhanced	O
by	O
the	O
inhibition	O
of	O
prostaglandin	B:C3813211
E2	I:C3813211
signaling	O
.	O

Because	O
the	O
levels	O
of	O
IFN	O
-β	I:C0015980
were	O
lower	O
in	O
AH23848	O
-	O
treated	O
mice	O
but	O
the	O
level	O
of	O
IL	O
-	I:C0021760
6	I:C0021760
was	O
similar	O
,	O
over	O
-	I:C0007613
production	I:C0007613
of	O
pathogenic	O
IFN	O
-β	I:C0015980
was	O
modulated	O
and	O
the	O
generation	O
of	O
IFN	O
-γ	I:C0021745
-	O
producing	O
T	O
cell	I:C0039194
responses	O
was	O
enhanced	O
by	O
the	O
inhibition	O
of	O
prostaglandin	O
E2	I:C3813211
signaling	B:C0037083
.	O

These	O
results	O
strongly	O
suggest	O
that	O
excessive	O
activation	B:C1148560
of	O
the	O
NLRP3	O
inflammasome	I:C3156614
and	O
downstream	O
prostaglandin	O
E2	I:C3813211
signaling	O
contribute	O
to	O
the	O
pathogenesis	O
of	O
Theiler	O
's	I:C0206425
murine	I:C0206425
encephalomyelitis	I:C0206425
virus	I:C0206425
-	O
induced	O
demyelinating	O
disease	I:C0011303
.	O

These	O
results	O
strongly	O
suggest	O
that	O
excessive	O
activation	O
of	O
the	O
NLRP3	B:C3156614
inflammasome	I:C3156614
and	O
downstream	O
prostaglandin	O
E2	I:C3813211
signaling	O
contribute	O
to	O
the	O
pathogenesis	O
of	O
Theiler	O
's	I:C0206425
murine	I:C0206425
encephalomyelitis	I:C0206425
virus	I:C0206425
-	O
induced	O
demyelinating	O
disease	I:C0011303
.	O

These	O
results	O
strongly	O
suggest	O
that	O
excessive	O
activation	O
of	O
the	O
NLRP3	O
inflammasome	I:C3156614
and	O
downstream	B:C0522506
prostaglandin	O
E2	I:C3813211
signaling	O
contribute	O
to	O
the	O
pathogenesis	O
of	O
Theiler	O
's	I:C0206425
murine	I:C0206425
encephalomyelitis	I:C0206425
virus	I:C0206425
-	O
induced	O
demyelinating	O
disease	I:C0011303
.	O

These	O
results	O
strongly	O
suggest	O
that	O
excessive	O
activation	O
of	O
the	O
NLRP3	O
inflammasome	I:C3156614
and	O
downstream	O
prostaglandin	B:C3813211
E2	I:C3813211
signaling	O
contribute	O
to	O
the	O
pathogenesis	O
of	O
Theiler	O
's	I:C0206425
murine	I:C0206425
encephalomyelitis	I:C0206425
virus	I:C0206425
-	O
induced	O
demyelinating	O
disease	I:C0011303
.	O

These	O
results	O
strongly	O
suggest	O
that	O
excessive	O
activation	O
of	O
the	O
NLRP3	O
inflammasome	I:C3156614
and	O
downstream	O
prostaglandin	O
E2	I:C3813211
signaling	B:C0037083
contribute	O
to	O
the	O
pathogenesis	O
of	O
Theiler	O
's	I:C0206425
murine	I:C0206425
encephalomyelitis	I:C0206425
virus	I:C0206425
-	O
induced	O
demyelinating	O
disease	I:C0011303
.	O

These	O
results	O
strongly	O
suggest	O
that	O
excessive	O
activation	O
of	O
the	O
NLRP3	O
inflammasome	I:C3156614
and	O
downstream	O
prostaglandin	O
E2	I:C3813211
signaling	O
contribute	O
to	O
the	O
pathogenesis	B:C0699748
of	O
Theiler	O
's	I:C0206425
murine	I:C0206425
encephalomyelitis	I:C0206425
virus	I:C0206425
-	O
induced	O
demyelinating	O
disease	I:C0011303
.	O

These	O
results	O
strongly	O
suggest	O
that	O
excessive	O
activation	O
of	O
the	O
NLRP3	O
inflammasome	I:C3156614
and	O
downstream	O
prostaglandin	O
E2	I:C3813211
signaling	O
contribute	O
to	O
the	O
pathogenesis	O
of	O
Theiler	B:C0206425
's	I:C0206425
murine	I:C0206425
encephalomyelitis	I:C0206425
virus	I:C0206425
-	O
induced	O
demyelinating	O
disease	I:C0011303
.	O

These	O
results	O
strongly	O
suggest	O
that	O
excessive	O
activation	O
of	O
the	O
NLRP3	O
inflammasome	I:C3156614
and	O
downstream	O
prostaglandin	O
E2	I:C3813211
signaling	O
contribute	O
to	O
the	O
pathogenesis	O
of	O
Theiler	O
's	I:C0206425
murine	I:C0206425
encephalomyelitis	I:C0206425
virus	I:C0206425
-	O
induced	O
demyelinating	B:C0011303
disease	I:C0011303
.	O

